Related Experiment Video
Updated: Dec 27, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
The alterations of mitochondrial DNA in coronary heart disease
Haochang Hu1, Ying Lin1, Xiaofeng Xu1
1School of Medicine, Ningbo University, Ningbo, Zhejiang, China.
Insights
Mitochondrial DNA (mtDNA) defects, including mutations and copy number changes, are linked to coronary heart disease (CHD). These alterations contribute to oxidative stress and energy deficits, impacting atherosclerosis and myocardial ischemia.
Area of Science:
- Cardiovascular Science
- Mitochondrial Biology
- Genetics
Background:
- Coronary heart disease (CHD) is a leading cause of mortality, characterized by atherosclerosis and potential ischemic events like myocardial infarction.
- Mitochondria are vital for cellular energy production (ATP) via oxidative phosphorylation (OXPHOS).
- Mitochondrial dysfunction, stemming from mitochondrial DNA (mtDNA) alterations, can lead to increased reactive oxygen species (ROS) and reduced ATP levels, promoting oxidative stress.
Purpose of the Study:
- To review the role of mtDNA mutations, copy number variations, and haplogroups in the development and progression of CHD.
- To highlight the potential of mtDNA defects as biomarkers for early diagnosis, prognosis, and therapeutic targets in atherosclerosis and CHD.
Main Methods:
- Literature review synthesizing current research on mtDNA alterations and CHD.
- Analysis of studies investigating the association between mtDNA mutations, copy number, haplogroups, and cardiovascular disease.
- Examination of the mechanistic links between mitochondrial dysfunction and atherosclerotic processes.
Main Results:
- mtDNA alterations (mutations, copy number changes, haplogroups) are associated with impaired OXPHOS function.
- Mitochondrial dysfunction contributes to increased oxidative stress and reduced ATP production, exacerbating atherosclerosis.
- These genetic and functional changes in mitochondria are implicated in the pathogenesis of CHD and myocardial ischemic injury.
Conclusions:
- mtDNA defects are significant contributors to the pathophysiology of atherosclerosis and CHD.
- mtDNA alterations offer potential for developing novel diagnostic, prognostic, and therapeutic strategies for CHD patients.
- Further research into mtDNA's role is crucial for advancing cardiovascular medicine.
Abstract:
Coronary heart disease (CHD) is the major cause of death in modern society. CHD is characterized by atherosclerosis, which could lead to vascular cavity stenosis or obstruction, resulting in ischemic cardiac conditions such as angina and myocardial infarction. In terms of the mitochondrion, the main function is to produce adenosine triphosphate (ATP) for cells. And the alterations (including mutations, altered copy number and haplogroups) of mitochondrial DNA (mtDNA) are associated with the abnormal expression of oxidative phosphorylation (OXPHOS) system, resulting in mitochondrial dysfunction, then leading to perturbation on the electron transport chain and increased ROS generation and reduction in ATP level, contributing to ATP-producing disorders and oxidative stress, which may further accelerate development or vulnerability of atherosclerosis and myocardial ischemic injury. Therefore, the mtDNA defects may play an important role in making an early diagnosis, identifying disease-specific biomarkers and therapeutic targets, and predicting outcomes for patients with atherosclerosis and CHD. In this review, we aim to summarize the contribution of mtDNA mutations, altered mtDNA copy number and mtDNA haplogroups on the occurrence and development of CHD.
More Related Videos
Related Concept Videos
Animal Mitochondrial Genetics
Mitochondrial Membranes
Mitochondria
Coronary Artery Disease I: Introduction
The Inner Mitochondrial Membrane
Coronary Artery Disease II: Pathophysiology

